Literature DB >> 10487857

Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2.

K A Kelley1, L Ho, D Winger, J Freire-Moar, C B Borelli, P S Aisen, G M Pasinetti.   

Abstract

In this study we describe the generation of a transgenic mouse model with neuronal overexpression of the human cyclooxygenase-2, h(COX)-2, to explore its role in excitotoxicity. We report that overexpression of neuronal hCOX-2 potentiates the intensity and lethality of kainic acid excitotoxicity in coincidence with potentiation of expression of the immediate early genes c-fos and zif-268. In vitro studies extended the in vivo findings and revealed that glutamate excitotoxicity is potentiated in primary cortico-hippocampal neurons derived from hCOX-2 transgenic mice, possibly through potentiation of mitochondrial impairment. This study is the first to demonstrate a cause-effect relationship between neuronal COX-2 expression and excitotoxicity. This model system will allow the systematic examination of the role of COX-2 in mechanisms of neurodegeneration that involve excitatory amino acid pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487857      PMCID: PMC1866889          DOI: 10.1016/S0002-9440(10)65199-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.

Authors:  A Oka; S Takashima
Journal:  Neuroreport       Date:  1997-03-24       Impact factor: 1.837

Review 2.  Self-promotion? Intimate connections between APC and prostaglandin H synthase-2.

Authors:  S M Prescott; R L White
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

3.  Requirement for superoxide in excitotoxic cell death.

Authors:  M Patel; B J Day; J D Crapo; I Fridovich; J O McNamara
Journal:  Neuron       Date:  1996-02       Impact factor: 17.173

4.  Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease.

Authors:  G Tocco; J Freire-Moar; S S Schreiber; S H Sakhi; P S Aisen; G M Pasinetti
Journal:  Exp Neurol       Date:  1997-04       Impact factor: 5.330

5.  Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies.

Authors:  P L McGeer; M Schulzer; E G McGeer
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

6.  Beta-secretase processing of the beta-amyloid precursor protein in transgenic mice is efficient in neurons but inefficient in astrocytes.

Authors:  J Zhao; L Paganini; L Mucke; M Gordon; L Refolo; M Carman; S Sinha; T Oltersdorf; I Lieberburg; L McConlogue
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

7.  DNA fragmentation and Prolonged expression of c-fos, c-jun, and hsp70 in kainic acid-induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase.

Authors:  T Kondo; F R Sharp; J Honkaniemi; S Mikawa; C J Epstein; P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  1997-03       Impact factor: 6.200

8.  IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage.

Authors:  E Fattori; D Lazzaro; P Musiani; A Modesti; T Alonzi; G Ciliberto
Journal:  Eur J Neurosci       Date:  1995-12-01       Impact factor: 3.386

9.  Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response.

Authors:  C Cao; K Matsumura; K Yamagata; Y Watanabe
Journal:  Brain Res       Date:  1995-10-30       Impact factor: 3.252

10.  Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist.

Authors:  V L Marcheselli; N G Bazan
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

View more
  48 in total

Review 1.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

2.  Cyclooxygenase-2 expression and effect of celecoxib in flurothyl-induced neonatal seizure.

Authors:  Doo Kwun Kim; Tae Jung Jang
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

Review 3.  Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?

Authors:  Lap Ho; Weiping Qin; Breton S Stetka; Giulio M Pasinetti
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  In Silico Modeling of Novel Drug Ligands for Treatment of Concussion Associated Tauopathy.

Authors:  Wei Zhao; Lap Ho; Jun Wang; Weina Bi; Shrishailam Yemul; Libby Ward; Daniel Freire; Paolo Mazzola; Justin Brathwaite; Mihaly Mezei; Roberto Sanchez; Gregory A Elder; Giulio Maria Pasinetti
Journal:  J Cell Biochem       Date:  2016-07-12       Impact factor: 4.429

Review 5.  Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.

Authors:  Greg M Cole; Sally A Frautschy
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-04       Impact factor: 4.388

6.  Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration.

Authors:  Weiping Qin; Wei Zhao; Lap Ho; Jun Wang; Kenneth Walsh; Sam Gandy; Giulio Maria Pasinetti
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

7.  Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.

Authors:  Lap Ho; Mario G Ferruzzi; Elsa M Janle; Jun Wang; Bing Gong; Tzu-Ying Chen; Jessica Lobo; Bruce Cooper; Qing Li Wu; Stephen T Talcott; Susan S Percival; James E Simon; Giulio Maria Pasinetti
Journal:  FASEB J       Date:  2012-10-24       Impact factor: 5.191

8.  Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death.

Authors:  Ava L Taylor; Joseph V Bonventre; Tracy F Uliasz; James A Hewett; Sandra J Hewett
Journal:  J Neurochem       Date:  2008-06-28       Impact factor: 5.372

9.  Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death.

Authors:  Noel G Carlson; Monica A Rojas; Jonathan W Redd; Philip Tang; Blair Wood; Kenneth E Hill; John W Rose
Journal:  J Neuroinflammation       Date:  2010-04-13       Impact factor: 8.322

10.  S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10.

Authors:  Weiping Qin; Lap Ho; Jun Wang; Elaine Peskind; Giulio Maria Pasinetti
Journal:  PLoS One       Date:  2009-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.